(Press-News.org)
Chronic alcohol consumption profoundly alters gene expression in key brain regions involved in reward, impulse control, and decision-making, according to a study led by researchers at the Institute for Neurosciences, a joint center of Miguel Hernández University of Elche (UMH) and the Spanish National Research Council (CSIC). Published in the journal Addiction, the work provides new insight into the biological basis of alcohol addiction and points toward potential therapeutic targets.
“Alcohol use disorder is one of the leading causes of disease and death worldwide, yet despite its enormous social and health impact, available treatment options remain limited,” explains UMH professor Jorge Manzanares, senior author of the study. “Understanding what changes in the brain after decades of alcohol consumption is essential for developing more effective therapies,” he adds.
To address this question, the researchers analyzed post-mortem brain tissue from individuals who had consumed alcohol chronically for an average of 35 years. The study focused on the endocannabinoid system, a key neurobiological network involved in reward, motivation, and addictive behaviors.
The endocannabinoid system regulates fundamental brain functions such as pleasure, mood, memory, and stress response. It consists of receptors—including CB1 and CB2—their endogenous ligands, and enzymes responsible for ligand degradation, such as FAAH and MGLL. “This system acts as a fine-tuned modulator of brain activity and plays a central role in reward and motivation,” Manzanares explains.
Previous studies had shown that alcohol interacts with the endocannabinoid system, but evidence from human brain tissue was scarce. This study provides a detailed picture of how chronic alcohol use alters the expression of key endocannabinoid genes in brain regions critical to addiction.
Researchers examined two core components of the mesocorticolimbic system: the prefrontal cortex, involved in judgment, planning, and decision-making, and the nucleus accumbens, a central hub for reward processing and habit formation.
Compared with control samples from individuals without addiction, brain tissue from people with alcohol use disorder showed marked gene expression imbalances. Expression of the CB1 receptor gene increased by 125% in the prefrontal cortex and by 78% in the nucleus accumbens. “CB1 is closely linked to reinforcement of addictive behaviors and relapse risk,” explains UMH professor María Salud García-Gutiérrez, first author of the study.
In contrast, expression of the CB2 receptor gene decreased by approximately 50% in both regions. “Because CB2 has neuroprotective and anti-inflammatory functions, its reduction suggests a weakening of the brain’s defenses against alcohol-induced damage,” García-Gutiérrez notes.
The study also revealed striking alterations in GPR55, a receptor long considered ‘orphan’ due to uncertainty about its natural ligand. GPR55 expression increased by 19% in the prefrontal cortex but dropped by 51% in the nucleus accumbens. This is the first study to document changes in GPR55 gene expression in humans with alcohol use disorder.
In addition, the researchers detected region-specific changes in FAAH, the enzyme responsible for degrading anandamide, an endocannabinoid involved in anxiety and reward. FAAH gene expression was reduced in the prefrontal cortex but increased by 24% in the nucleus accumbens, potentially altering endocannabinoid availability and signaling.
A major strength of the study is the use of brain tissue samples from the New South Wales Tissue Resource Centre in Australia. All samples came from individuals with chronic alcohol use disorder who did not consume other illicit drugs, allowing the researchers to isolate the specific effects of alcohol on the human brain. “This approach provides a much clearer picture of how alcohol alone reshapes gene expression in brain regions central to addiction,” García-Gutiérrez explains.
According to the authors, these findings help explain why individuals with alcohol use disorder show increased relapse vulnerability and impaired executive control. Identifying which components of the endocannabinoid system are altered, and where in the brain these changes occur, opens the door to more targeted and personalized therapeutic strategies.
In addition to Jorge Manzanares and María Salud García-Gutiérrez, the study was authored by Abraham Bailén Torregrosa, Francisco Navarrete, and Auxiliadora Aracil, members of the Translational Neuropsychopharmacology of Neurological and Psychiatric Disorders group at the Institute for Neurosciences and affiliated with the Primary Care Addiction Research Network of the Carlos III Health Institute and the Alicante Institute for Health and Biomedical Research (ISABIAL). Gabriel Rubio, researcher at the Hospital 12 de Octubre Health Research Institute (i+12), also contributed to the study.
The research was funded by the Carlos III Health Institute, the Spanish Ministry of Science and Innovation, and the Spanish Ministry of Health, through national research networks in addiction and health, with additional support from ISABIAL. The Institute for Neurosciences is accredited as a Severo Ochoa Centre of Excellence.
END
Historical redlining, a 1930s–1960s residential segregation policy, has been linked to shorter survival time in people with breast cancer. New research reveals that this association has changed over time, with disparities narrowing until recently. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Under the redlining policy, federal agencies and banks created maps that designated neighborhoods as A (“best”) to D (“hazardous,” colored red ...
Panic attacks are sudden bouts of intense fear without an obvious cause. An estimated 10% of people experience at least one panic attack in their lifetime. But between 2% and 3% of the population have such frequent and severe panic attacks that they meet the criteria for the debilitating condition ‘panic disorder’.
The current standard of care for panic disorder is cognitive behavioral therapy (CBT), with or without antidepressants. A technique of CBT with proven efficacy is ‘interoceptive exposure’, where therapists trigger common ...
Reduce, reuse, recycle, and rethink can be applied in Canadian operating rooms (ORs) to increase environmental sustainability, advises a new guideline published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251192.
As the Canadian health care system produces almost 5% of the country’s greenhouse gas emissions and 200 000 tonnes of other pollutants, many generated in ORs, it makes sense to focus on reducing these harms.
An evidence-based ...
In recent years, popular culture has made ‘boundaries’ a saviour, touted as the way to prevent burnout at work and fallout with friends. But how do we make them, and what makes a boundary ‘healthy’?
Psychotherapist Lynn Somerfield suggests that maintaining healthy boundaries around relationships, work and personal beliefs is crucial to good mental health.
In her new book, The Seeds of Change – How Therapists Cultivate Personal Growth, she draws on patient case histories and insights from her ...
Deaths due to synthetic opioids nitazenes have likely been underestimated by up to a third.
King’s College London research, published today in Clinical Toxicology, sheds light on the UK’s growing synthetic opioid problem.
The presence of nitazenes on the unregulated drug market has risen steeply in the last seven years – prompting UK and international bodies to issue public health warnings about their use.
Nitazenes are a class of synthetic opioids which can have potencies of up to 500 times that of heroin. They can be readily manufactured at low cost. These potent synthetic opioids were ...
Tokyo, Japan – Scientists from Tokyo Metropolitan University have uncovered how fertilized rice seeds begin to divide and establish their “body axis.” Using a new imaging method, they discovered that while the first cell divides in an asymmetric way initially, this is followed by random growth and the apparently “collective” determination of a body axis. This is a significant break with known pathways, a rare glimpse into the birth and growth of plant embryos.
A key puzzle in plant science is how plants ...
Researchers have developed a new strategy to engineer biochar with dramatically enhanced sunlight-driven chemical activity, opening promising pathways for environmental remediation and pollutant transformation. The findings demonstrate how combining biochar with artificially synthesized humic substances can significantly boost its ability to drive light-powered reduction reactions that influence metal cycling and contaminant transformation in natural environments.
The study, recently published in Biochar, introduces a co-engineering approach that integrates biochar with artificial humic substances created through a controlled ...
https://doi.org/10.1016/j.apsb.2025.09.014
This new article publication from Acta Pharmaceutica Sinica B, discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.
Vaccines represent one of the most potent strategies for protecting humans from the threat of infectious diseases. Conventional vaccines elicit acquired immunity by mimicking pathogen characteristics; however, their protective efficacy is limited by inadequate spatiotemporal control of ...
https://doi.org/10.1016/j.apsb.2025.10.005
This new article publication from Acta Pharmaceutica Sinica B, discusses the deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy.
Phenotypic screening has played an important role in discovering innovative small-molecule drugs and clinical candidates with unique molecular mechanisms of action. However, conducting cell-based high-throughput screening from vast compound libraries is extremely time-consuming and expensive. Fortunately, deep learning has provided a new paradigm for identifying ...
https://doi.org/10.1016/j.apsb.2025.10.031
This new article publication from Acta Pharmaceutica Sinica B, discusses DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer.
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by the poorest prognosis, and poses a significant threat to women's health. In this study two novel prieurianin-type limonoids extracted from Munronia henryi were identified, one of which, named DHL-11, exhibited antitumor activity ...
